

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 7.13626546 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 7.13626546 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.13626546 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.13626546 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.13626546 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 7.13626546 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.36541468 |
| 8 | negative regulation of interleukin-12 production (GO:0032695) | 5.50887755 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.37245049 |
| 10 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.16394277 |
| 11 | microglial cell activation (GO:0001774) | 4.95367191 |
| 12 | regulation of mononuclear cell migration (GO:0071675) | 4.76553411 |
| 13 | negative regulation of granulocyte differentiation (GO:0030853) | 4.55838919 |
| 14 | pinocytosis (GO:0006907) | 4.53469850 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.48647258 |
| 16 | response to host immune response (GO:0052572) | 4.48585556 |
| 17 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.48585556 |
| 18 | glycosphingolipid catabolic process (GO:0046479) | 4.36473857 |
| 19 | positive regulation of interferon-alpha production (GO:0032727) | 4.17564483 |
| 20 | phospholipid homeostasis (GO:0055091) | 4.15069887 |
| 21 | neutrophil mediated immunity (GO:0002446) | 4.13109594 |
| 22 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.12637408 |
| 23 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.08525418 |
| 24 | response to host (GO:0075136) | 4.08525418 |
| 25 | response to host defenses (GO:0052200) | 4.08525418 |
| 26 | oligosaccharide catabolic process (GO:0009313) | 3.95623310 |
| 27 | regulation of interferon-alpha production (GO:0032647) | 3.95100957 |
| 28 | amino sugar catabolic process (GO:0046348) | 3.95071192 |
| 29 | I-kappaB phosphorylation (GO:0007252) | 3.94877472 |
| 30 | glycolipid catabolic process (GO:0019377) | 3.90994199 |
| 31 | negative regulation of cell killing (GO:0031342) | 3.88181590 |
| 32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.88181590 |
| 33 | N-acetylneuraminate metabolic process (GO:0006054) | 3.84559942 |
| 34 | apoptotic cell clearance (GO:0043277) | 3.83381091 |
| 35 | T-helper 1 type immune response (GO:0042088) | 3.80364381 |
| 36 | macrophage activation (GO:0042116) | 3.78878288 |
| 37 | regulation of macrophage chemotaxis (GO:0010758) | 3.78145876 |
| 38 | mannose metabolic process (GO:0006013) | 3.76356805 |
| 39 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.76301480 |
| 40 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.74913904 |
| 41 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.73895263 |
| 42 | detection of molecule of bacterial origin (GO:0032490) | 3.73425169 |
| 43 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.73106958 |
| 44 | myeloid cell activation involved in immune response (GO:0002275) | 3.67977474 |
| 45 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.66378594 |
| 46 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.65743935 |
| 47 | positive regulation of mast cell degranulation (GO:0043306) | 3.65743935 |
| 48 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.61307545 |
| 49 | adenosine receptor signaling pathway (GO:0001973) | 3.60970364 |
| 50 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.59941808 |
| 51 | response to muramyl dipeptide (GO:0032495) | 3.58119246 |
| 52 | positive regulation of B cell differentiation (GO:0045579) | 3.57173893 |
| 53 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.52631201 |
| 54 | natural killer cell mediated immunity (GO:0002228) | 3.52631201 |
| 55 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.52474294 |
| 56 | hyaluronan catabolic process (GO:0030214) | 3.49995939 |
| 57 | positive regulation of leukocyte degranulation (GO:0043302) | 3.49768127 |
| 58 | germinal center formation (GO:0002467) | 3.48615284 |
| 59 | lipoprotein transport (GO:0042953) | 3.48393331 |
| 60 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.46109856 |
| 61 | positive regulation of antigen processing and presentation (GO:0002579) | 3.45985620 |
| 62 | ceramide catabolic process (GO:0046514) | 3.45865886 |
| 63 | macroautophagy (GO:0016236) | 3.43142032 |
| 64 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.42799889 |
| 65 | response to peptidoglycan (GO:0032494) | 3.38662054 |
| 66 | positive regulation of mast cell activation (GO:0033005) | 3.38191738 |
| 67 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.36950962 |
| 68 | negative regulation of lipid storage (GO:0010888) | 3.36145709 |
| 69 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.35363914 |
| 70 | immunoglobulin mediated immune response (GO:0016064) | 3.35249697 |
| 71 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.33211252 |
| 72 | adhesion of symbiont to host cell (GO:0044650) | 3.32107114 |
| 73 | virion attachment to host cell (GO:0019062) | 3.32107114 |
| 74 | positive regulation of cholesterol efflux (GO:0010875) | 3.31290721 |
| 75 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.30601297 |
| 76 | NIK/NF-kappaB signaling (GO:0038061) | 3.26042317 |
| 77 | monocyte chemotaxis (GO:0002548) | 3.25389466 |
| 78 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.25125280 |
| 79 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.22368447 |
| 80 | myeloid dendritic cell differentiation (GO:0043011) | 3.20616291 |
| 81 | response to thyroid hormone (GO:0097066) | 3.18375053 |
| 82 | positive regulation of heat generation (GO:0031652) | 3.18007854 |
| 83 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.15116272 |
| 84 | regulation of cholesterol storage (GO:0010885) | 3.14844820 |
| 85 | positive regulation of p38MAPK cascade (GO:1900745) | 3.12665545 |
| 86 | regulation of podosome assembly (GO:0071801) | 3.11351087 |
| 87 | negative regulation of interleukin-6 production (GO:0032715) | 3.10431190 |
| 88 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.09886659 |
| 89 | barbed-end actin filament capping (GO:0051016) | 3.07032979 |
| 90 | cell adhesion mediated by integrin (GO:0033627) | 3.06821782 |
| 91 | detection of external biotic stimulus (GO:0098581) | 3.05918796 |
| 92 | membrane lipid catabolic process (GO:0046466) | 3.05763365 |
| 93 | adhesion of symbiont to host (GO:0044406) | 3.01826134 |
| 94 | negative regulation of interleukin-1 production (GO:0032692) | 3.00784890 |
| 95 | regulation of integrin activation (GO:0033623) | 2.99366152 |
| 96 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.98300264 |
| 97 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.98154641 |
| 98 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.97871825 |
| 99 | myeloid dendritic cell activation (GO:0001773) | 2.97710750 |
| 100 | neutrophil activation (GO:0042119) | 2.97046110 |
| 101 | regulation of chemokine biosynthetic process (GO:0045073) | 2.96809461 |
| 102 | response to lipoprotein particle (GO:0055094) | 2.96521886 |
| 103 | myeloid leukocyte mediated immunity (GO:0002444) | 2.95793096 |
| 104 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.95204419 |
| 105 | detection of other organism (GO:0098543) | 2.94311447 |
| 106 | positive regulation of cholesterol transport (GO:0032376) | 2.93248715 |
| 107 | positive regulation of sterol transport (GO:0032373) | 2.93248715 |
| 108 | macrophage differentiation (GO:0030225) | 2.92472541 |
| 109 | sphingolipid catabolic process (GO:0030149) | 2.91398696 |
| 110 | granulocyte activation (GO:0036230) | 2.89281904 |
| 111 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.87505974 |
| 112 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.87383881 |
| 113 | histamine secretion (GO:0001821) | 2.87153876 |
| 114 | regulation of mast cell degranulation (GO:0043304) | 2.85712874 |
| 115 | cytidine deamination (GO:0009972) | 2.84003577 |
| 116 | cytidine metabolic process (GO:0046087) | 2.84003577 |
| 117 | cytidine catabolic process (GO:0006216) | 2.84003577 |
| 118 | regulation of fever generation (GO:0031620) | 2.82179511 |
| 119 | positive regulation of interferon-beta production (GO:0032728) | 2.81502018 |
| 120 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.80958083 |
| 121 | positive regulation of receptor recycling (GO:0001921) | 2.77642056 |
| 122 | basic amino acid transport (GO:0015802) | 2.77113762 |
| 123 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.76607020 |
| 124 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.76062382 |
| 125 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.76046109 |
| 126 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.74513722 |
| 127 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.74274679 |
| 128 | B cell homeostasis (GO:0001782) | 2.74050313 |
| 129 | cellular response to lipopolysaccharide (GO:0071222) | 2.73829656 |
| 130 | regulation of sequestering of triglyceride (GO:0010889) | 2.73741738 |
| 131 | regulation of antigen processing and presentation (GO:0002577) | 2.73078781 |
| 132 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.72949754 |
| 133 | positive regulation of chemokine secretion (GO:0090197) | 2.72267571 |
| 134 | B cell mediated immunity (GO:0019724) | 2.71720866 |
| 135 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.71621562 |
| 136 | detection of biotic stimulus (GO:0009595) | 2.71583485 |
| 137 | dendritic cell differentiation (GO:0097028) | 2.70346458 |
| 138 | viral entry into host cell (GO:0046718) | 2.69256094 |
| 139 | respiratory burst (GO:0045730) | 2.69232637 |
| 140 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.69062999 |
| 141 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.68365649 |
| 142 | response to laminar fluid shear stress (GO:0034616) | 2.68294735 |
| 143 | cellular response to molecule of bacterial origin (GO:0071219) | 2.68131708 |
| 144 | B cell receptor signaling pathway (GO:0050853) | 2.67639259 |
| 145 | response to protozoan (GO:0001562) | 2.67463781 |
| 146 | positive regulation of leukocyte apoptotic process (GO:2000108) | 2.64975657 |
| 147 | G-protein coupled receptor internalization (GO:0002031) | 2.64698183 |
| 148 | protein kinase C signaling (GO:0070528) | 2.64639471 |
| 149 | substrate-dependent cell migration (GO:0006929) | 2.64444852 |
| 150 | negative regulation of interleukin-17 production (GO:0032700) | 2.63084475 |
| 151 | positive regulation of T cell apoptotic process (GO:0070234) | 2.62930676 |
| 152 | positive regulation of phagocytosis (GO:0050766) | 2.61781860 |
| 153 | regulation of gamma-delta T cell activation (GO:0046643) | 2.61063535 |
| 154 | response to fluid shear stress (GO:0034405) | 2.60340046 |
| 155 | lysosome organization (GO:0007040) | 2.57977351 |
| 156 | lytic vacuole organization (GO:0080171) | 2.57977351 |
| 157 | low-density lipoprotein particle clearance (GO:0034383) | 2.57064567 |
| 158 | cellular extravasation (GO:0045123) | 2.55367023 |
| 159 | modulation by symbiont of host cellular process (GO:0044068) | 2.53330762 |
| 160 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.52199304 |
| 161 | regulation of mast cell activation (GO:0033003) | 2.51936997 |
| 162 | regulation of leukocyte degranulation (GO:0043300) | 2.51571904 |
| 163 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.49479494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.00669200 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.93770215 |
| 3 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.62922003 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.27033662 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.23814406 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.23506883 |
| 7 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.48801260 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.84897601 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.75853745 |
| 10 | SPI1_23127762_ChIP-Seq_K562_Human | 2.74583505 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.72609615 |
| 12 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.40469164 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.37869466 |
| 14 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.33521017 |
| 15 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.28178631 |
| 16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.26521897 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.20684639 |
| 18 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.16906134 |
| 19 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.10123934 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.02326300 |
| 21 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.98504315 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.98488158 |
| 23 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.97182174 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91093318 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.89805325 |
| 26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.88173721 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.81377502 |
| 28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.76445446 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.74904038 |
| 30 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.73144979 |
| 31 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.71450999 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.70388435 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.70080215 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68394581 |
| 35 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.62463813 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.59887144 |
| 37 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.54346479 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.51480995 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47154046 |
| 40 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46972218 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46885347 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.44974804 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.43802949 |
| 44 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.43783828 |
| 45 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.43480618 |
| 46 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.43107968 |
| 47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40236881 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39619953 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.38707488 |
| 50 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.38420706 |
| 51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36924438 |
| 52 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.36127562 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35943388 |
| 54 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34259092 |
| 55 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34156198 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.32299436 |
| 57 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.30578178 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30463266 |
| 59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29873528 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29035303 |
| 61 | MYC_22102868_ChIP-Seq_BL_Human | 1.27482816 |
| 62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25592159 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21965045 |
| 64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21116768 |
| 65 | * MAF_26560356_Chip-Seq_TH1_Human | 1.20419678 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15229100 |
| 67 | GATA2_19941826_ChIP-Seq_K562_Human | 1.14259258 |
| 68 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.13380190 |
| 69 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13307463 |
| 70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11788394 |
| 71 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10936068 |
| 72 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10647040 |
| 73 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10487679 |
| 74 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09141779 |
| 75 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08564948 |
| 76 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05720444 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04825059 |
| 78 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04573579 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03587619 |
| 80 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03559589 |
| 81 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03555596 |
| 82 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.02879603 |
| 83 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00942153 |
| 84 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.00813828 |
| 85 | MYB_26560356_Chip-Seq_TH1_Human | 1.00190443 |
| 86 | * MAF_26560356_Chip-Seq_TH2_Human | 1.00016537 |
| 87 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00004631 |
| 88 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99941933 |
| 89 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99572208 |
| 90 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99570989 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99311810 |
| 92 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98411284 |
| 93 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.97822813 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97234878 |
| 95 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.96812461 |
| 96 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96443501 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96063975 |
| 98 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95302222 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94804521 |
| 100 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.93833350 |
| 101 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92781511 |
| 102 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92465845 |
| 103 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92001178 |
| 104 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91846120 |
| 105 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90681747 |
| 106 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90405280 |
| 107 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90082093 |
| 108 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90036696 |
| 109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89490561 |
| 110 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.88772953 |
| 111 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.88712622 |
| 112 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88338267 |
| 113 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.87768172 |
| 114 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87026408 |
| 115 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86969666 |
| 116 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86731815 |
| 117 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85834137 |
| 118 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85218575 |
| 119 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84929662 |
| 120 | MYB_26560356_Chip-Seq_TH2_Human | 0.83995584 |
| 121 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.83995096 |
| 122 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.83425910 |
| 123 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83425910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 7.55459635 |
| 2 | MP0005058_abnormal_lysosome_morphology | 5.26371623 |
| 3 | MP0003172_abnormal_lysosome_physiology | 4.10355949 |
| 4 | MP0009840_abnormal_foam_cell | 2.88595576 |
| 5 | MP0005174_abnormal_tail_pigmentation | 2.81963314 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.63565516 |
| 7 | MP0003303_peritoneal_inflammation | 2.59147562 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.48989941 |
| 9 | MP0002419_abnormal_innate_immunity | 2.46902419 |
| 10 | MP0000015_abnormal_ear_pigmentation | 2.40574086 |
| 11 | MP0004510_myositis | 2.37558337 |
| 12 | MP0006082_CNS_inflammation | 2.32506411 |
| 13 | MP0003436_decreased_susceptibility_to | 2.23636927 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.22913834 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.22218116 |
| 16 | MP0009278_abnormal_bone_marrow | 2.20998200 |
| 17 | MP0003690_abnormal_glial_cell | 2.00762582 |
| 18 | MP0010368_abnormal_lymphatic_system | 1.97989724 |
| 19 | MP0005167_abnormal_blood-brain_barrier | 1.90231676 |
| 20 | MP0003183_abnormal_peptide_metabolism | 1.89255144 |
| 21 | MP0008004_abnormal_stomach_pH | 1.75939766 |
| 22 | MP0003724_increased_susceptibility_to | 1.73202496 |
| 23 | MP0003566_abnormal_cell_adhesion | 1.71633336 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.68597319 |
| 25 | MP0005000_abnormal_immune_tolerance | 1.62525088 |
| 26 | MP0001800_abnormal_humoral_immune | 1.60303223 |
| 27 | MP0005387_immune_system_phenotype | 1.59863449 |
| 28 | MP0001790_abnormal_immune_system | 1.59863449 |
| 29 | MP0005257_abnormal_intraocular_pressure | 1.59022316 |
| 30 | MP0000604_amyloidosis | 1.57557721 |
| 31 | MP0005025_abnormal_response_to | 1.57394311 |
| 32 | MP0001879_abnormal_lymphatic_vessel | 1.50768342 |
| 33 | MP0002723_abnormal_immune_serum | 1.50320201 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.50188901 |
| 35 | MP0005451_abnormal_body_composition | 1.49730791 |
| 36 | MP0005310_abnormal_salivary_gland | 1.49409679 |
| 37 | MP0000371_diluted_coat_color | 1.48449195 |
| 38 | MP0006054_spinal_hemorrhage | 1.46063620 |
| 39 | MP0003828_pulmonary_edema | 1.44708025 |
| 40 | MP0001958_emphysema | 1.44344891 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.43585468 |
| 42 | MP0008438_abnormal_cutaneous_collagen | 1.42874089 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.41933779 |
| 44 | MP0002254_reproductive_system_inflammat | 1.36847889 |
| 45 | MP0005670_abnormal_white_adipose | 1.36816402 |
| 46 | MP0003453_abnormal_keratinocyte_physiol | 1.36318258 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.36271010 |
| 48 | MP0000685_abnormal_immune_system | 1.29665036 |
| 49 | MP0001819_abnormal_immune_cell | 1.29103589 |
| 50 | MP0002420_abnormal_adaptive_immunity | 1.27335771 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.27052130 |
| 52 | MP0008469_abnormal_protein_level | 1.25832358 |
| 53 | MP0004947_skin_inflammation | 1.22506691 |
| 54 | MP0000343_altered_response_to | 1.22479576 |
| 55 | MP0003705_abnormal_hypodermis_morpholog | 1.21663839 |
| 56 | MP0001851_eye_inflammation | 1.19951527 |
| 57 | MP0002138_abnormal_hepatobiliary_system | 1.15550606 |
| 58 | MP0003448_altered_tumor_morphology | 1.14641377 |
| 59 | MP0002405_respiratory_system_inflammati | 1.12682804 |
| 60 | MP0010307_abnormal_tumor_latency | 1.12183023 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.12118618 |
| 62 | MP0004130_abnormal_muscle_cell | 1.11864365 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.10155199 |
| 64 | MP0000767_abnormal_smooth_muscle | 1.09601003 |
| 65 | MP0002396_abnormal_hematopoietic_system | 1.08207535 |
| 66 | MP0005165_increased_susceptibility_to | 1.06649007 |
| 67 | MP0003329_amyloid_beta_deposits | 1.06420113 |
| 68 | MP0001845_abnormal_inflammatory_respons | 1.05920167 |
| 69 | MP0005671_abnormal_response_to | 1.05303632 |
| 70 | MP0000920_abnormal_myelination | 1.05173827 |
| 71 | MP0003075_altered_response_to | 1.04881694 |
| 72 | MP0000689_abnormal_spleen_morphology | 1.02902305 |
| 73 | MP0005083_abnormal_biliary_tract | 1.01215459 |
| 74 | MP0001873_stomach_inflammation | 1.00803307 |
| 75 | MP0009785_altered_susceptibility_to | 1.00693579 |
| 76 | MP0005397_hematopoietic_system_phenotyp | 1.00147567 |
| 77 | MP0001545_abnormal_hematopoietic_system | 1.00147567 |
| 78 | MP0001915_intracranial_hemorrhage | 0.99509079 |
| 79 | MP0001542_abnormal_bone_strength | 0.98254863 |
| 80 | MP0001853_heart_inflammation | 0.97411740 |
| 81 | MP0002332_abnormal_exercise_endurance | 0.94807940 |
| 82 | MP0005360_urolithiasis | 0.93825748 |
| 83 | MP0009763_increased_sensitivity_to | 0.92991237 |
| 84 | MP0005164_abnormal_response_to | 0.91536999 |
| 85 | MP0002006_tumorigenesis | 0.90747560 |
| 86 | MP0000609_abnormal_liver_physiology | 0.90636925 |
| 87 | MP0005390_skeleton_phenotype | 0.90618467 |
| 88 | MP0001663_abnormal_digestive_system | 0.87818797 |
| 89 | MP0010329_abnormal_lipoprotein_level | 0.87686772 |
| 90 | MP0003091_abnormal_cell_migration | 0.87668589 |
| 91 | MP0000249_abnormal_blood_vessel | 0.86747929 |
| 92 | MP0003279_aneurysm | 0.86590383 |
| 93 | MP0004883_abnormal_blood_vessel | 0.85230714 |
| 94 | MP0000716_abnormal_immune_system | 0.84797079 |
| 95 | MP0004381_abnormal_hair_follicle | 0.82971231 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 0.82594071 |
| 97 | MP0009764_decreased_sensitivity_to | 0.80872559 |
| 98 | MP0005595_abnormal_vascular_smooth | 0.80362142 |
| 99 | MP0003795_abnormal_bone_structure | 0.78916564 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 0.78306281 |
| 101 | MP0003634_abnormal_glial_cell | 0.77437800 |
| 102 | MP0002933_joint_inflammation | 0.77420700 |
| 103 | MP0002722_abnormal_immune_system | 0.75733983 |
| 104 | MP0005197_abnormal_uvea_morphology | 0.75590542 |
| 105 | MP0005076_abnormal_cell_differentiation | 0.74191846 |
| 106 | MP0002398_abnormal_bone_marrow | 0.73216548 |
| 107 | MP0003252_abnormal_bile_duct | 0.71249163 |
| 108 | MP0010155_abnormal_intestine_physiology | 0.71124830 |
| 109 | MP0000858_altered_metastatic_potential | 0.70357501 |
| 110 | MP0001849_ear_inflammation | 0.70288590 |
| 111 | MP0005166_decreased_susceptibility_to | 0.70284756 |
| 112 | MP0002429_abnormal_blood_cell | 0.69985667 |
| 113 | MP0005647_abnormal_sex_gland | 0.68539690 |
| 114 | MP0004185_abnormal_adipocyte_glucose | 0.67858363 |
| 115 | MP0002877_abnormal_melanocyte_morpholog | 0.67747166 |
| 116 | MP0001243_abnormal_dermal_layer | 0.67370521 |
| 117 | MP0005365_abnormal_bile_salt | 0.67265365 |
| 118 | MP0002139_abnormal_hepatobiliary_system | 0.66949831 |
| 119 | MP0003195_calcinosis | 0.65081223 |
| 120 | MP0002277_abnormal_respiratory_mucosa | 0.65005710 |
| 121 | MP0005023_abnormal_wound_healing | 0.64652698 |
| 122 | MP0003045_fibrosis | 0.64513926 |
| 123 | MP0002928_abnormal_bile_duct | 0.64414712 |
| 124 | MP0002837_dystrophic_cardiac_calcinosis | 0.63324097 |
| 125 | MP0000598_abnormal_liver_morphology | 0.62510069 |
| 126 | MP0008260_abnormal_autophagy | 0.62411924 |
| 127 | MP0003879_abnormal_hair_cell | 0.58353227 |
| 128 | MP0008874_decreased_physiological_sensi | 0.57901801 |
| 129 | MP0002090_abnormal_vision | 0.57268636 |
| 130 | MP0005319_abnormal_enzyme/_coenzyme | 0.56612119 |
| 131 | MP0003633_abnormal_nervous_system | 0.55753419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.00037405 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.86689888 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.71768024 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 5.58582073 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 4.94240503 |
| 6 | Glomerulonephritis (HP:0000099) | 4.78319228 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.69546143 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.35121537 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.35121537 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 4.35121537 |
| 11 | Dysostosis multiplex (HP:0000943) | 4.23332440 |
| 12 | Axonal loss (HP:0003447) | 4.16809072 |
| 13 | Complement deficiency (HP:0004431) | 4.02929394 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.67044665 |
| 15 | Nuclear cataract (HP:0100018) | 3.64361873 |
| 16 | Hematochezia (HP:0002573) | 3.59035014 |
| 17 | Neurofibrillary tangles (HP:0002185) | 3.58699380 |
| 18 | Disinhibition (HP:0000734) | 3.49067290 |
| 19 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.45059670 |
| 20 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.45059670 |
| 21 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.45059670 |
| 22 | Gingivitis (HP:0000230) | 3.40176195 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.39908914 |
| 24 | Periodontitis (HP:0000704) | 3.31919752 |
| 25 | Abnormality of complement system (HP:0005339) | 3.31814399 |
| 26 | Thick nail (HP:0001805) | 3.26700621 |
| 27 | Mucopolysacchariduria (HP:0008155) | 3.23325394 |
| 28 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.23325394 |
| 29 | Cerebral aneurysm (HP:0004944) | 3.22333417 |
| 30 | Abnormality of macrophages (HP:0004311) | 3.21703599 |
| 31 | Recurrent skin infections (HP:0001581) | 3.19619161 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 3.14113801 |
| 33 | Myocardial infarction (HP:0001658) | 3.10103559 |
| 34 | Nephritis (HP:0000123) | 3.09384243 |
| 35 | Pathologic fracture (HP:0002756) | 3.09068775 |
| 36 | Upper motor neuron abnormality (HP:0002127) | 2.98416174 |
| 37 | Optic neuritis (HP:0100653) | 2.93174187 |
| 38 | Retrobulbar optic neuritis (HP:0100654) | 2.93174187 |
| 39 | Prostate neoplasm (HP:0100787) | 2.92738448 |
| 40 | Joint hemorrhage (HP:0005261) | 2.80411422 |
| 41 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.79339323 |
| 42 | Peripheral demyelination (HP:0011096) | 2.79102023 |
| 43 | Global brain atrophy (HP:0002283) | 2.78419863 |
| 44 | Apathy (HP:0000741) | 2.78036612 |
| 45 | Amyloidosis (HP:0011034) | 2.77595100 |
| 46 | Purpura (HP:0000979) | 2.75899593 |
| 47 | Loss of speech (HP:0002371) | 2.75426021 |
| 48 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.70577440 |
| 49 | Spontaneous hematomas (HP:0007420) | 2.70106851 |
| 50 | Diminished motivation (HP:0000745) | 2.70038169 |
| 51 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.69543783 |
| 52 | Neuronal loss in central nervous system (HP:0002529) | 2.61433080 |
| 53 | Asymmetric septal hypertrophy (HP:0001670) | 2.56089843 |
| 54 | Increased serum ferritin (HP:0003281) | 2.55706454 |
| 55 | Thoracic kyphosis (HP:0002942) | 2.54921847 |
| 56 | Cerebral inclusion bodies (HP:0100314) | 2.54781289 |
| 57 | Premature loss of primary teeth (HP:0006323) | 2.53553290 |
| 58 | Urethral obstruction (HP:0000796) | 2.52911170 |
| 59 | Personality changes (HP:0000751) | 2.52298444 |
| 60 | Colitis (HP:0002583) | 2.50869807 |
| 61 | Gingival bleeding (HP:0000225) | 2.44313739 |
| 62 | Stomatitis (HP:0010280) | 2.42649087 |
| 63 | Progressive neurologic deterioration (HP:0002344) | 2.42111580 |
| 64 | Bone pain (HP:0002653) | 2.42109430 |
| 65 | Obstructive lung disease (HP:0006536) | 2.40927067 |
| 66 | Chronic obstructive pulmonary disease (HP:0006510) | 2.40927067 |
| 67 | Conjunctival telangiectasia (HP:0000524) | 2.36562003 |
| 68 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.35944719 |
| 69 | Distal lower limb amyotrophy (HP:0008944) | 2.33050989 |
| 70 | Neurodegeneration (HP:0002180) | 2.30797021 |
| 71 | Dementia (HP:0000726) | 2.26888731 |
| 72 | Increased CSF protein (HP:0002922) | 2.26241983 |
| 73 | Abnormal platelet function (HP:0011869) | 2.26151436 |
| 74 | Impaired platelet aggregation (HP:0003540) | 2.26151436 |
| 75 | Retinal atrophy (HP:0001105) | 2.25613949 |
| 76 | Agnosia (HP:0010524) | 2.24025844 |
| 77 | Hypercholesterolemia (HP:0003124) | 2.22372781 |
| 78 | Abnormality of the thoracic spine (HP:0100711) | 2.20674182 |
| 79 | Pustule (HP:0200039) | 2.18436300 |
| 80 | Recurrent fungal infections (HP:0002841) | 2.17951848 |
| 81 | Osteolytic defects of the hand bones (HP:0009699) | 2.16607101 |
| 82 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.16607101 |
| 83 | Myositis (HP:0100614) | 2.16257297 |
| 84 | Pulmonary infiltrates (HP:0002113) | 2.16113916 |
| 85 | J-shaped sella turcica (HP:0002680) | 2.15929950 |
| 86 | Mediastinal lymphadenopathy (HP:0100721) | 2.15106268 |
| 87 | Hemoptysis (HP:0002105) | 2.13363585 |
| 88 | Abnormality of iron homeostasis (HP:0011031) | 2.11686385 |
| 89 | Petechiae (HP:0000967) | 2.10697155 |
| 90 | Pulmonary artery stenosis (HP:0004415) | 2.09773099 |
| 91 | Distal lower limb muscle weakness (HP:0009053) | 2.09562450 |
| 92 | Epistaxis (HP:0000421) | 2.08401630 |
| 93 | Disproportionate tall stature (HP:0001519) | 2.08066326 |
| 94 | Submucous cleft hard palate (HP:0000176) | 2.07899498 |
| 95 | Osteomyelitis (HP:0002754) | 2.07239524 |
| 96 | Bruising susceptibility (HP:0000978) | 2.07015371 |
| 97 | Hepatosplenomegaly (HP:0001433) | 2.03963190 |
| 98 | Polyneuropathy (HP:0001271) | 2.02150946 |
| 99 | Keratoconjunctivitis sicca (HP:0001097) | 2.01145410 |
| 100 | Prolonged bleeding time (HP:0003010) | 1.99284433 |
| 101 | Prolonged neonatal jaundice (HP:0006579) | 1.98587402 |
| 102 | Supranuclear gaze palsy (HP:0000605) | 1.94970837 |
| 103 | Inflammation of the large intestine (HP:0002037) | 1.92553314 |
| 104 | Malnutrition (HP:0004395) | 1.91894078 |
| 105 | Esophageal varix (HP:0002040) | 1.90846865 |
| 106 | Facial diplegia (HP:0001349) | 1.90763098 |
| 107 | Metaphyseal irregularity (HP:0003025) | 1.89932983 |
| 108 | Memory impairment (HP:0002354) | 1.88791018 |
| 109 | Cardiomegaly (HP:0001640) | 1.87448960 |
| 110 | Mutism (HP:0002300) | 1.87384258 |
| 111 | Abnormality of the nasal mucosa (HP:0000433) | 1.87145922 |
| 112 | Frequent falls (HP:0002359) | 1.85742149 |
| 113 | Progressive visual loss (HP:0000529) | 1.85400487 |
| 114 | Leukocytosis (HP:0001974) | 1.85104595 |
| 115 | Meningitis (HP:0001287) | 1.84027599 |
| 116 | Vertebral compression fractures (HP:0002953) | 1.83486893 |
| 117 | Abnormality of vision evoked potentials (HP:0000649) | 1.83481516 |
| 118 | Striae distensae (HP:0001065) | 1.83474842 |
| 119 | Orchitis (HP:0100796) | 1.83314745 |
| 120 | Arterial tortuosity (HP:0005116) | 1.81409082 |
| 121 | Aortic aneurysm (HP:0004942) | 1.80557431 |
| 122 | Abnormality of the periventricular white matter (HP:0002518) | 1.80467297 |
| 123 | Inappropriate behavior (HP:0000719) | 1.80442077 |
| 124 | Abnormality of the lumbar spine (HP:0100712) | 1.80393611 |
| 125 | Spondylolisthesis (HP:0003302) | 1.79933312 |
| 126 | Basal ganglia calcification (HP:0002135) | 1.79424450 |
| 127 | Acrocyanosis (HP:0001063) | 1.79130507 |
| 128 | Keratoconjunctivitis (HP:0001096) | 1.79061800 |
| 129 | Tetany (HP:0001281) | 1.78693561 |
| 130 | Large earlobe (HP:0009748) | 1.78224597 |
| 131 | Vasculitis (HP:0002633) | 1.77013701 |
| 132 | Absent frontal sinuses (HP:0002688) | 1.76534286 |
| 133 | Hypoalphalipoproteinemia (HP:0003233) | 1.76294793 |
| 134 | Recurrent viral infections (HP:0004429) | 1.74883140 |
| 135 | Pulmonary embolism (HP:0002204) | 1.74299017 |
| 136 | Interstitial pulmonary disease (HP:0006530) | 1.73335949 |
| 137 | Mucosal telangiectasiae (HP:0100579) | 1.71087392 |
| 138 | Joint stiffness (HP:0001387) | 1.69222241 |
| 139 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.67016866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 4.27554027 |
| 2 | NME2 | 3.32647794 |
| 3 | CAMK1D | 3.19685489 |
| 4 | TAOK3 | 3.06649375 |
| 5 | KIT | 3.01474142 |
| 6 | CAMK1G | 2.90619349 |
| 7 | TYK2 | 2.85951454 |
| 8 | RIPK4 | 2.63587630 |
| 9 | TIE1 | 2.63381124 |
| 10 | TTN | 2.57810349 |
| 11 | DDR2 | 2.50785606 |
| 12 | BLK | 2.48599065 |
| 13 | IRAK3 | 2.45612593 |
| 14 | KDR | 2.38081274 |
| 15 | CSF1R | 2.32260395 |
| 16 | MAP3K14 | 2.27831581 |
| 17 | MAP3K11 | 2.22177028 |
| 18 | SIK2 | 2.11767440 |
| 19 | TBK1 | 2.08044593 |
| 20 | PRPF4B | 2.07264547 |
| 21 | FES | 2.06602383 |
| 22 | TAOK2 | 2.04072081 |
| 23 | IRAK4 | 2.02387049 |
| 24 | ERN1 | 1.92172990 |
| 25 | JAK1 | 1.79466509 |
| 26 | TAOK1 | 1.75072293 |
| 27 | PTK6 | 1.69033885 |
| 28 | MAP2K3 | 1.57827463 |
| 29 | HCK | 1.56835382 |
| 30 | CDC42BPA | 1.50575599 |
| 31 | MAP4K1 | 1.49001575 |
| 32 | ACVR1B | 1.46120890 |
| 33 | EPHB1 | 1.43155928 |
| 34 | DAPK2 | 1.40526687 |
| 35 | RIPK1 | 1.39847585 |
| 36 | MOS | 1.36150275 |
| 37 | IKBKB | 1.33030227 |
| 38 | ABL2 | 1.31967073 |
| 39 | NEK9 | 1.29953965 |
| 40 | ZAP70 | 1.27339471 |
| 41 | IKBKE | 1.27039467 |
| 42 | MAP3K13 | 1.26601920 |
| 43 | PIM2 | 1.24819810 |
| 44 | JAK3 | 1.22899071 |
| 45 | CDK12 | 1.20757262 |
| 46 | CSK | 1.20230719 |
| 47 | GRK7 | 1.16254707 |
| 48 | CDK6 | 1.16199735 |
| 49 | JAK2 | 1.12555464 |
| 50 | FGR | 1.12017678 |
| 51 | SCYL2 | 1.11083285 |
| 52 | TRIB3 | 1.10754694 |
| 53 | TGFBR1 | 1.08925811 |
| 54 | CLK1 | 1.06372162 |
| 55 | MAP3K1 | 1.05395140 |
| 56 | MAPK12 | 1.02270974 |
| 57 | MAP3K3 | 1.02179729 |
| 58 | PKN2 | 0.99713177 |
| 59 | LCK | 0.99585589 |
| 60 | PAK4 | 0.97770992 |
| 61 | TNK2 | 0.92930543 |
| 62 | PTK2B | 0.89497503 |
| 63 | LYN | 0.87260368 |
| 64 | EGFR | 0.87218510 |
| 65 | CAMKK2 | 0.86804392 |
| 66 | TESK2 | 0.85839539 |
| 67 | SYK | 0.84858887 |
| 68 | TESK1 | 0.84068302 |
| 69 | MAPK7 | 0.83291285 |
| 70 | ADRBK2 | 0.81557449 |
| 71 | IRAK2 | 0.80779589 |
| 72 | PKN1 | 0.78981510 |
| 73 | CHUK | 0.78197168 |
| 74 | BTK | 0.75915199 |
| 75 | SGK3 | 0.74599400 |
| 76 | BRD4 | 0.74414645 |
| 77 | BMPR2 | 0.73719606 |
| 78 | EPHB2 | 0.71484752 |
| 79 | ICK | 0.69881236 |
| 80 | MAP2K6 | 0.69686808 |
| 81 | MAPK15 | 0.67978700 |
| 82 | IRAK1 | 0.66744328 |
| 83 | ITK | 0.66738077 |
| 84 | MAP3K5 | 0.66529286 |
| 85 | SGK2 | 0.66336822 |
| 86 | TRPM7 | 0.66225003 |
| 87 | STK10 | 0.64990585 |
| 88 | TYRO3 | 0.64088944 |
| 89 | CAMK4 | 0.64078260 |
| 90 | PRKAA2 | 0.63579233 |
| 91 | TEC | 0.62935914 |
| 92 | PDGFRA | 0.62831424 |
| 93 | PDGFRB | 0.61981229 |
| 94 | MARK2 | 0.58215402 |
| 95 | RPS6KC1 | 0.56935003 |
| 96 | RPS6KL1 | 0.56935003 |
| 97 | MAP3K10 | 0.56709208 |
| 98 | MTOR | 0.56470019 |
| 99 | PTK2 | 0.56041307 |
| 100 | YES1 | 0.53872834 |
| 101 | PDPK1 | 0.53795091 |
| 102 | TXK | 0.53485489 |
| 103 | ABL1 | 0.50866635 |
| 104 | INSRR | 0.50614320 |
| 105 | SIK3 | 0.49894095 |
| 106 | SIK1 | 0.49187979 |
| 107 | MAPK4 | 0.48368529 |
| 108 | FYN | 0.47602843 |
| 109 | PAK2 | 0.47121951 |
| 110 | SRC | 0.45884173 |
| 111 | PDK1 | 0.45613003 |
| 112 | MARK3 | 0.44379901 |
| 113 | IGF1R | 0.44149733 |
| 114 | MAP3K6 | 0.43395767 |
| 115 | FGFR4 | 0.42593866 |
| 116 | GSK3A | 0.42572060 |
| 117 | PIK3CG | 0.42530302 |
| 118 | CAMKK1 | 0.42254929 |
| 119 | SGK1 | 0.40945046 |
| 120 | RPS6KA2 | 0.40816843 |
| 121 | EIF2AK2 | 0.39705398 |
| 122 | PRKD2 | 0.39646783 |
| 123 | CDK9 | 0.38442541 |
| 124 | DAPK3 | 0.37819277 |
| 125 | PIM1 | 0.37789443 |
| 126 | BMX | 0.37679717 |
| 127 | DMPK | 0.37183193 |
| 128 | PRKD1 | 0.36407854 |
| 129 | STK4 | 0.34588746 |
| 130 | ARAF | 0.33758936 |
| 131 | MATK | 0.33442822 |
| 132 | PRKG2 | 0.33184815 |
| 133 | ERBB2 | 0.32711092 |
| 134 | PRKCD | 0.30741993 |
| 135 | CDK4 | 0.30094829 |
| 136 | INSR | 0.29356429 |
| 137 | RPS6KA6 | 0.28127143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.14360366 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.85979890 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 3.19681973 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.12581608 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.84865722 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.54741260 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.32797257 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.24164317 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.19882085 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.14875963 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.09996225 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.08053995 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 1.97312218 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.94775330 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.87375186 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.85732144 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.76311616 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.73635241 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.71468822 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.58970495 |
| 21 | Phagosome_Homo sapiens_hsa04145 | 1.58651395 |
| 22 | Lysine degradation_Homo sapiens_hsa00310 | 1.39115331 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.37258677 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33948162 |
| 25 | ABC transporters_Homo sapiens_hsa02010 | 1.31745357 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.31122252 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.29775813 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29351938 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.23439594 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19045927 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13842082 |
| 32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.11196176 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09488531 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.04476305 |
| 35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.03144568 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.03061808 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01111432 |
| 38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.96796304 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95906224 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 0.94811943 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94504960 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91036640 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90821034 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 0.90140864 |
| 45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.89652651 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.88149729 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 0.87750421 |
| 48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.87412940 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 0.86742069 |
| 50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.86440084 |
| 51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.85272042 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.84734664 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84713833 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.83678510 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83529804 |
| 56 | Bladder cancer_Homo sapiens_hsa05219 | 0.83224834 |
| 57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80891842 |
| 58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.80865001 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80417715 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 0.80224270 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79384939 |
| 62 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.78702712 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76597544 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.76489517 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76407475 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76211324 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.74699305 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74254722 |
| 69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70856479 |
| 70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70335110 |
| 71 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.69846420 |
| 72 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.67292193 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64927992 |
| 74 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64618184 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 0.64573434 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.64528766 |
| 77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64448099 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64213668 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.62917773 |
| 80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61878434 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59096050 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57919774 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.56629948 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56362222 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55524337 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53661085 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53382174 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52633828 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52522165 |
| 90 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.52316522 |
| 91 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.51660856 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.51429097 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50844787 |
| 94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50540126 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50373907 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48237259 |
| 97 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47808053 |
| 98 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45691848 |
| 99 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.45274679 |
| 100 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44400999 |
| 101 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42694473 |
| 102 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.41406651 |
| 103 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.40320759 |
| 104 | Bile secretion_Homo sapiens_hsa04976 | 0.40304469 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40113824 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39697461 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38305816 |
| 108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37584365 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.36088932 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36049380 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33552912 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33114723 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32584181 |
| 114 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.32540941 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31848713 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31418490 |
| 117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30117913 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29890558 |
| 119 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29812187 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29186562 |
| 121 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.23394003 |
| 122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21849483 |
| 123 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.18454021 |
| 124 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.18052239 |
| 125 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.16583638 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16524214 |

